Skip to main content
. 2022 Apr 14;12(4):989. doi: 10.3390/diagnostics12040989
AF Atrial Fibrillation
ANP/NT-proANP Atrial natriuretic peptide/N-terminal-proANP
ASCVD Atherosclerotic cardiovascular disease
BNP/NT-proBNP Brain/B-type natriuretic peptide/N-terminal-proBNP
CKD Chronic kidney disease
CSS Clinical summary score
CV Cardiovascular
EF Ejection fraction
eGFR Estimated glomerular filtration rate
ESRD End-stage renal disease
HF Heart failure
HFrEF Heart failure with reduced ejection fraction
HFpEF Heart failure with preserved ejection fraction
HHF Hospitalization due to heart failure
HR Hazard ratio
KCCQ Kansas City Cardiomyopathy Questionnaire
LVEF Left ventricular ejection fraction
MACE Major adverse cardiac events
NO Nitric oxide
NPs Natriuretic peptides
NYHA New York Heart Association
OMT Optimal medical therapy
RAAS Renin-angiotensin-aldosterone system
SGLT-2i Sodium-glucose cotransporter-2 inhibitors
SNS Sympathetic nervous system
T2DM/T1DM Type 2/Type 1 diabetes mellitus